Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Esther M. te Poele"'
Autor:
Wim J. E. Tissing, Esther M. te Poele, Eveline S. J. M. de Bont, Erik A. H. Loeffen, H. Marike Boezen
Publikováno v:
The Cochrane Library
Background Chemotherapy-induced neutropenia is a common adverse effect in children with cancer. Due to the high relative risk of infections and infectious complications, standard care for children with cancer and febrile neutropenia consists of routi
Autor:
Tiny G. J. Meeuwsen-de Boer, Willem A. Kamps, Dirkje S. Postma, Marc Bierings, Esther M. te Poele, Gerard H. Koppelman, Mateusz Siedlinski, Eveline S. J. M. de Bont, P. J. Anne de Pagter, Hendrika Boezen, Frank J. G. Scherpen
Publikováno v:
British Journal of Haematology. 157:132-135
Publikováno v:
The Cochrane Library
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3cd73f728856a1e29c5d4fbbb04e732
https://doi.org/10.1002/14651858.cd008382
https://doi.org/10.1002/14651858.cd008382
Publikováno v:
Critical reviews in oncology/hematology. 72(1)
Children with cancer treated with chemotherapy are susceptible to bacterial infections and serious infectious complications. However, fever and neutropenia can also result from other causes, for which no antibiotic treatment is needed. In the past de
Autor:
Esther M. te Poele, Willem A. Kamps, H. Marike Boezen, Auke Beishuizen, Eveline S. J. M. de Bont, Tom Revesz, Jos P.M. Bökkerink, Anjo J.P. Veerman, Ilse J.M. Nijhuis, Claudi S.M. Oude Nijhuis
Publikováno v:
European Journal of Cancer, 43(17), 2532-2536. ELSEVIER SCI LTD
European Journal of Cancer, 43, 17, pp. 2532-6
European Journal of Cancer, 43, 2532-2536. Elsevier Ltd.
European Journal of Cancer, 43, 2532-6
European Journal of Cancer, 43, 17, pp. 2532-6
European Journal of Cancer, 43, 2532-2536. Elsevier Ltd.
European Journal of Cancer, 43, 2532-6
Contains fulltext : 51905.pdf (Publisher’s version ) (Closed access) We report an increased incidence of infectious deaths during maintenance treatment of the ninth protocol for acute lymphoblastic leukaemia of the Dutch Childhood Oncology Group (D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a74a53e0431bd8de4be316c4132e356e
https://doi.org/10.1016/j.ejca.2007.07.002
https://doi.org/10.1016/j.ejca.2007.07.002
Autor:
Willem Kamps, Esther M. te Poele, Jan A Leeuw, Rienk Y. J. Tamminga, Aleida Postma, Evelina S. J. M. de Bont
Publikováno v:
Journal of pediatric hematology/oncology. 27(11)
Chemotherapy-induced neutropenia is a major dose-limiting side effect of intensive chemotherapy in cancer patients. Recently, pegfilgrastim (a product with a long half-life, resulting in once-per-cycle dosage) was introduced to prevent neutropenia in
Autor:
Esther M te Poele
Publikováno v:
Journal of Pediatric Hematology/Oncology; Nov2005, Vol. 27 Issue 11, p627-629, 3p